Entrada Therapeutics SG&A Expense (TTM) Analysis

Entrada Therapeutics Inc (TRDA)

17.07 +0.63 (+3.83%) USD | NASDAQ | Oct 04, 16:00

17.08 +0.01 (+0.06%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
June 30, 2024	34.82M
March 31, 2024	33.75M
December 31, 2023	32.29M
September 30, 2023	33.53M
June 30, 2023	32.98M
March 31, 2023	32.14M
December 31, 2022	30.64M

Date	Value
September 30, 2022	26.84M
June 30, 2022	23.72M
March 31, 2022	19.46M
December 31, 2021	15.20M
September 30, 2021	11.10M
June 30, 2021	8.521M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

8.521M

Minimum

Jun 2021

34.82M

Maximum

Jun 2024

25.77M

Average

30.64M

Median

Dec 2022

SG&A Expense (TTM) Benchmarks